CDKL5 and craniodiaphyseal dysplasia: Of late, researchers have proposed minimal diagnostic criteria for CDD patients, which include the genetic finding of a pathogenic or likely pathogenic variant in CDKL5, in association with early-onset epilepsy and severe developmental delay [6].